Dr. Jose B. Vazquez-Tanus

Cardiology
2225 Ponce Bypass, 
Ponce, PR 
Accepting New Patients
2225 Ponce Bypass, 
Ponce, PR 

Overview

Jose Vazquez-Tanus is a Cardiologist in Ponce, Puerto Rico. His top areas of expertise are Stable Angina, Metabolic Syndrome, and Fainting. Dr. Vazquez-Tanus is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Cardiology

Licenses

Internal Medicine in PR

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
First Medical Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medical Card System
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
  • PPO
MMM Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Plan De Salud Menonita
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

2225 Ponce Bypass, Ponce, PR 00717

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Active_not_recruiting
Publish Date: April 01, 2026
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drug: LY3502970
Study Phase: Phase 2
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: November 02, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Semaglutide
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D
Enrollment Status: Completed
Publish Date: March 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

1 Total Publications

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial.
Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial.
Journal: Journal of the American Heart Association
Published: November 08, 2021
Similar Doctors
Expertise in
2
conditions
Dr. Jose R. Martinez-Barroso
Cardiology
Expertise in
2
conditions
Dr. Jose R. Martinez-Barroso
Cardiology
Manati, PR 
 (30.6 miles away)
787-854-6361
Experience:
44+ years
Languages Spoken:
English
See accepted insurances

Jose Martinez-Barroso is a Cardiologist in Manati, Puerto Rico. Dr. Martinez-Barroso has been practicing medicine for over 44 years is highly rated in 2 conditions, according to our data. His top areas of expertise are Acute Coronary Syndrome, Necrosis, Hypertensive Heart Disease, Gastrostomy, and Hip Replacement.

Expertise in
3
conditions
Dr. Fernando A. Lopez
Cardiology
Expertise in
3
conditions
Dr. Fernando A. Lopez
Cardiology
Cayey, PR 
 (31.5 miles away)
787-263-5136
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Fernando Lopez is a Cardiologist in Cayey, Puerto Rico. Dr. Lopez is highly rated in 3 conditions, according to our data. His top areas of expertise are Metabolic Syndrome, Prinzmetal's Variant Angina, Coronary Artery Spasm, and Hypertensive Heart Disease.

Expertise in
2
conditions
Dr. David R. Bermudez-Nunez
Cardiology
Expertise in
2
conditions
Dr. David R. Bermudez-Nunez
Cardiology
San German, PR 
 (28.5 miles away)
787-892-4965
Languages Spoken:
English
See accepted insurances

David Bermudez-Nunez is a Cardiologist in San German, Puerto Rico. Dr. Bermudez-Nunez is highly rated in 2 conditions, according to our data. His top areas of expertise are Hypertensive Heart Disease, Pediatric Myocarditis, Metabolic Syndrome, and Necrosis.

Frequently Asked Questions about Dr. Jose B. Vazquez-Tanus

Is Dr. Jose B. Vazquez-Tanus a top-rated expert for Stable Angina?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jose B. Vazquez-Tanus is classified as an Experienced expert for Stable Angina, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jose B. Vazquez-Tanus specialize in?

While Dr. Jose B. Vazquez-Tanus is a Cardiology, they have specific expertise in Stable Angina, Metabolic Syndrome, and Fainting. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Jose B. Vazquez-Tanus participate in research or clinical trials?

Yes. Dr. Jose B. Vazquez-Tanus has published 1 articles and abstracts on conditions like Stable Angina. You can view a list of Dr. Jose B. Vazquez-Tanus's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jose B. Vazquez-Tanus accept my insurance?

Dr. Jose B. Vazquez-Tanus accepts most major insurance plans, including Blue Cross Blue Shield and First Medical Health Plan. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Vazquez-Tanus's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile